HYDERABAD, India & VANCOUVER, Canada – May 29, 2025 –
Mapmygenome, a pioneer in AI-powered genomics and personalized healthcare, has announced the strategic acquisition of Microbiome Insights, a globally recognized expert in microbial sequencing. This acquisition includes Microbiome Insights’ CAP-accredited laboratory in Canada and its extensive intellectual property, significantly enhancing Mapmygenome’s scientific capabilities and supporting its global growth strategy.
Microbiome Insights has supported over 600 clients worldwide through more than 1,000 advanced microbiome studies, serving as a trusted partner to academia, clinical researchers, and industry. Its founders—Dr. Brett Finlay, Dr. William Mohn, and Malcolm Kendall—are respected authorities in microbiome science.
Under the new structure, Microbiome Insights will continue to operate as a premier contract research organization (CRO), supporting global microbiome research. Meanwhile, Mapmygenome plans to introduce its integrated genomics and microbiome services to the North American market, making data-driven, holistic health solutions more widely available.
“The human microbiome plays a critical role in health. With this acquisition, we are now at the forefront of this field,” said Anu Acharya, Founder and CEO of Mapmygenome. “We’re gaining top-tier expertise in metagenomics, transcriptomics, and metabolomics—strengthening our offerings for academic, biotech, and clinical partners. This move also accelerates our North American presence and aligns with our plan to go public on the Indian market later this year.”
Malcolm Kendall, CEO of Microbiome Insights, added: “Partnering with Mapmygenome equips us to enhance service quality and scale faster. Together, we’ll set a new global standard for innovation by combining their genomics and AI expertise with our deep microbiome knowledge.”
Financial details of the transaction were not disclosed.
About Mapmygenome
Founded over a decade ago, Mapmygenome is a leading genomics company committed to preventive healthcare through personalized solutions. The company offers AI-powered genomic and microbiome testing, including at-home DNA kits and clinical-grade diagnostic tests, all backed by CAP-accredited labs and expert genetic counseling.
About Microbiome Insights
Microbiome Insights is a global CRO specializing in end-to-end microbiome sequencing and data analysis. With a diverse clientele across pharma, biotech, nutrition, cosmetics, and agriculture, the company has supported more than 1,000 studies, ranging from research and biomarker discovery to clinical trials and machine learning modeling.
Media Contact: Anu Acharya | anu@mapmygenome.ca | www.mapmygenome.ai
Malcolm Kendall | malcolm@microbiomeinsights.com | www.microbiomeinsights.com
